knowledge -WSS

knowledge

author：fashion 2025-09-27 12:22:58 - browse：6631

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Experts study whether long Covid risk adds up with each reinfection

WSS

More tobacco lobbyists active in statehouses

H5N1 bird flu virus started spreading in cows in Texas in December

MultiPlan and major insurers sued for alleged medical price

Health care needs a new profession: neuroimaging counseling

FTC falls short on scrutinizing hospital mergers, study says

UnitedHealth financials solid despite Change Healthcare cyberattack

knowledge

knowledge

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

Microbiome research is starting to find links to chronic diseases

United colonoscopy coverage change 'may cost lives,' doctors say

Biotech stock slump in 2023: awaiting the turnaround

ChatGPT in medicine: STAT answers readers' burning questions

CDC's new outbreak response network to include Northeastern

In age of alternative facts, a scholarly course on calling out crap

FDA panel to weigh approval of NurOwn, controversial ALS drug

DIEP, the 'gold standard' of breast reconstruction, is under threat

Melinda French Gates resigns from Gates Foundation

focus

CDC advisers recommend seasonal use of Pfizer RSV shot

Cholera vaccine supply gets boost as demand surges globally

FTC falls short on scrutinizing hospital mergers, study says

Key Senate committee drafts bipartisan bill to stem drug shortages

Senators: Long

Key Senate committee drafts bipartisan bill to stem drug shortages

hotspot

hotspot

focus

explore